Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Thrasos Therapeutics Inc.
DescriptionCyclic peptide that activates the bone morphogenetic protein (BMP) signaling pathway
Molecular Target Bone morphogenetic protein receptors
Mechanism of ActionBone morphogenetic proteins agonist
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase II
Standard IndicationRenal damage
Indication DetailsPrevent acute kidney injury (AKI) associated with cardiac surgery
Regulatory Designation U.S. - Fast Track (Prevent acute kidney injury (AKI) associated with cardiac surgery)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today